DN

David Nierengarten Wedbush Latest Price Targets & Analyst Ratings

Main Sector
Healthcare
Ratings Past Year
51
Avg Return
Past Year
16%
Success Rate
Past Year
0 %
Rating Distribution Past Year
Positive 78.6%
Neutral 19.6%
Negative 1.8%
Stock Rating Price Target Upside
Downside
Ratings
1 Year
Avg Return
1 Year
Success Rate
1 Year
Date
Neutral Downgraded
$12 1
28 May ‘25 9 months ago
Neutral Downgraded
$2
90%
downside
1
14 Mar ‘25 11 months ago